Analyst ratings, flows, short interest & sentiment
Key Questions
What is the current consensus analyst rating for UiPath (PATH)?
The consensus rating is Hold with an average price target of $13.81, according to Zacks #3 Hold trending down 6.9% month-over-month. Recent updates include Truist at $13, TD at $13, BofA at $12, BMO at $14, and Evercore cuts.
How has UiPath's stock performed recently?
The stock is trading at $11.24, down 6.9% over the past month with support at $10.75, -35% year-to-date, and 87% off its highs. It has been highlighted as oversold in several analyses.
What is the short interest in UiPath?
Short interest stands at 20.47%, positioning it among the more shorted large-cap tech stocks as of recent data.
Who are some major institutional investors in UiPath?
Strong 13F filings include Tetragon with 5.6% holding, Hudson Bay Capital Management, Udine Wealth Management, and Norges, indicating institutional interest.
What are some bullish analyst targets for UiPath?
Bullish views include Needham at $15, Alpha Spread at $15.81, Simply Wall St at $21.54, and Intellectia recommending dip-buying, with others like Gary and Julian calling it an oversold top pick.
Is UiPath considered an oversold stock?
Yes, articles highlight UiPath as one of the top oversold tech stocks to buy, with recommendations for AI portfolios due to its dip from highs.
What recent insider activity has occurred at UiPath?
Routine RSU and ESOP grants include CPO & CTO disclosures, COO & CFO receiving 306,748 RSUs, CAO granted 123,466 RSUs, and Malpani Form 3 filing, generally neutral impact.
What factors are influencing UiPath's analyst sentiment?
Sentiment reflects Hold consensus amid AI agent concerns, free cash flow post-Q1, competitive risks, but balanced by institutional buying and oversold status.
Cons Hold $13.81/Zacks #3 Hold trending (-6.9% mo) (Truist $13 post-Q1 FCF AI agents/TD $13/BofA $12/BMO $14/Evercore cuts), stock $11.24 -6.9% past mo ($10.75 supp) -35% YTD/87% highs (ex-1ADNNUnt/Intellectia ex-205bc5da/ac516f82/eee7628b/1AFoR7z0), short 20.47%; strong 13Fs Tetragon 5.6%/Hudson/Udine/Norges etc; Intellectia bullish dip-buy ex-cdf56fd7/Needham $15/Alpha $15.81/Simply $21.54/Gary/Julian/oversold top pick & AI portfolio recs (ex-3273b14d/bd9d42dc); RSU/ESOP routine incl Malpani Form3.